154 related articles for article (PubMed ID: 38260860)
1. Editorial: Pharmacogenetic landscape in human solid cancers.
Lastraioli E; Colombo F; Frullanti E
Front Oncol; 2023; 13():1343395. PubMed ID: 38260860
[No Abstract] [Full Text] [Related]
2. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
3. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics: from discovery to patient care.
Shin J; Kayser SR; Langaee TY
Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
[TBL] [Abstract][Full Text] [Related]
5. The Landscape of Clinical Implementation of Pharmacogenetic Testing in Central China: A Single-Center Study.
Zhang J; Qi G; Han C; Zhou Y; Yang Y; Wang X; Liu S; Zhang X
Pharmgenomics Pers Med; 2021; 14():1619-1628. PubMed ID: 34934339
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Chang WC; Tanoshima R; Ross CJD; Carleton BC
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
[TBL] [Abstract][Full Text] [Related]
7. The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil.
Diasio RB; Johnson MR
Pharmacology; 2000 Sep; 61(3):199-203. PubMed ID: 10971206
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescription.
Maillard M; Louveau B; Vilquin P; Goldwirt L; Thomas F; Mourah S
Therapie; 2022; 77(2):171-183. PubMed ID: 34922740
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.
Talebi Z; Sparreboom A; Colace SI
Methods Mol Biol; 2022; 2547():63-94. PubMed ID: 36068461
[TBL] [Abstract][Full Text] [Related]
10. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
[No Abstract] [Full Text] [Related]
11. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.
Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM
Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613
[TBL] [Abstract][Full Text] [Related]
12. The need to shift pharmacogenetic research from candidate gene to genome-wide association studies.
Linskey DW; Linskey DC; McLeod HL; Luzum JA
Pharmacogenomics; 2021 Nov; 22(17):1143-1150. PubMed ID: 34608812
[TBL] [Abstract][Full Text] [Related]
13. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS).
Bothos E; Ntoumou E; Kelaidoni K; Roukas D; Drakoulis N; Papasavva M; Karakostis FA; Moulos P; Karakostis K
J Transl Med; 2021 Apr; 19(1):151. PubMed ID: 33858454
[TBL] [Abstract][Full Text] [Related]
15. Using the PharmCAT tool for Pharmacogenetic clinical decision support.
Tippenhauer K; Philips M; Largiadèr C; Sariyar M
Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38055839
[TBL] [Abstract][Full Text] [Related]
16. [Perspectives of the use of pharmacogenetic tests in neurology and psychiatry].
Kostyuk GP; Zakharova NV; Reznik AM; Surkova EI; Ilinsky VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):131-135. PubMed ID: 31626230
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and pharmacogenomics: development, science, and translation.
Weinshilboum RM; Wang L
Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Beyond Red Light, Green Light: Examining the Role of Pharmacogenomics in Evidence-Based Care in Child and Adolescent Psychiatry.
Namerow LB; Ramsey LB; Malik S; Cortese S; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2022 Jan; 61(1):29-31. PubMed ID: 34767918
[TBL] [Abstract][Full Text] [Related]
19. Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics.
Mattison LK; Soong R; Diasio RB
Pharmacogenomics; 2002 Jul; 3(4):485-92. PubMed ID: 12164772
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman R
Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
